PPARgamma and metabolism: insights from the study of human genetic variants (Q35200033)

7 August 2017

1 reference

title

PPARgamma and metabolism: insights from the study of human genetic variants (English)

1 reference

7 August 2017

Mark Gurnell

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

published in

Clinical Endocrinology

1 reference

7 August 2017

volume

59

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

267-277

1 reference

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Interactions between subunits of the human epithelial sodium channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

CAP defines a second signalling pathway required for insulin-stimulated glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Hepatic peroxisome proliferation in rodents and its significance for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

A futile metabolic cycle activated in adipocytes by antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPAR(gamma) and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

21 January 2018

Lipoatrophy revisited

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Thiazolidinediones: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Adipogenesis and obesity: rounding out the big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Hepatic dysfunction associated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01767.X

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1046/J.1365-2265.2003.01767.X

15 July 2023

Identifiers

DOI

1 reference

7 August 2017

1 reference